Marwan Ghosn

Summary

Country: Lebanon

Publications

  1. ncbi Phase II trial of capecitabine and vinorelbine as first-line chemotherapy for metastatic breast cancer patients
    Marwan Ghosn
    Department of Oncology Hematology, Hotel Dieu de France University Hospital, Achrafieh, Blvd Alfred Naccache, P O Box 166830, Beirut, Lebanon, France
    Anticancer Res 26:2451-6. 2006
  2. ncbi FOLFOX-6 combination as the first-line treatment of locally advanced and/or metastatic pancreatic cancer
    Marwan Ghosn
    Hotel Dieu de France University Hospital, Beirut, Lebanon
    Am J Clin Oncol 30:15-20. 2007
  3. ncbi Sequential vinorelbine-capecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial
    Marwan Ghosn
    Department of Oncology, Hematology, Hotel Dieu de France University Hospital, Achrafieh, Blvd Alfred Naccache, P O Box 166830, Beirut, Lebanon
    Cancer Chemother Pharmacol 62:11-8. 2008
  4. ncbi Experience with palliative care in patients with advanced cancer at a tertiary care hospital in a developing country
    Marwan Ghosn
    Hotel Dieu de France University Hospital, Achrafieh, Beirut, Lebanon
    Support Care Cancer 19:573-5. 2011
  5. ncbi Triple-negative breast cancer in Lebanon: a case series
    Marwan Ghosn
    Saint Joseph University School of Medicine, Beirut, Lebanon
    Oncologist 16:1552-6. 2011
  6. ncbi Current strategies in the treatment of metastatic hormone-refractory prostate cancer
    Marwan Ghosn
    Hematology-Oncology Department, , Beirut, Lebanon
    Tunis Med 83:74. 2005
  7. ncbi Outcome of cancer patients admitted to the intensive care unit (ICU)
    Marwan Ghosn
    Department of Hematology-Oncology, , Beirut, Lebanon
    J Med Liban 50:132-6. 2002
  8. ncbi [A five-year experience in conformational radiotherapy in the treatment of prostate cancer. Evaluation of acute toxicity in 131 patients]
    Elie Nasr
    Service de Radiotherapie, Hotel Dieu de France, Université Saint Joseph, Beyrouth, Liban
    Prog Urol 15:36-9. 2005

Collaborators

  • Georges Chahine
  • Elie Nasr
  • Edward Chalouhi
  • Georges Chehade
  • Muhammad Bulbul
  • Maroun Moukarzel
  • Elie Nemr
  • Georges Fares
  • Antoine Abillamah
  • Michel Jabbour
  • Georges Ghazale
  • Pierre Sarkis
  • Raghid Khoury
  • Dolly Nehme Nasr
  • Sleiman Merhej

Detail Information

Publications8

  1. ncbi Phase II trial of capecitabine and vinorelbine as first-line chemotherapy for metastatic breast cancer patients
    Marwan Ghosn
    Department of Oncology Hematology, Hotel Dieu de France University Hospital, Achrafieh, Blvd Alfred Naccache, P O Box 166830, Beirut, Lebanon, France
    Anticancer Res 26:2451-6. 2006
    ..The aim of this multicenter phase II trial was to assess the combination of capecitabine and vinorelbine as first-line chemotherapy in patients with metastatic breast cancer (MBC)...
  2. ncbi FOLFOX-6 combination as the first-line treatment of locally advanced and/or metastatic pancreatic cancer
    Marwan Ghosn
    Hotel Dieu de France University Hospital, Beirut, Lebanon
    Am J Clin Oncol 30:15-20. 2007
    ..This phase II trial was conducted to investigate the efficacy of oxaliplatin, 5-FU, and folinic acid (FOLFOX-6) in previously untreated APC patients...
  3. ncbi Sequential vinorelbine-capecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial
    Marwan Ghosn
    Department of Oncology, Hematology, Hotel Dieu de France University Hospital, Achrafieh, Blvd Alfred Naccache, P O Box 166830, Beirut, Lebanon
    Cancer Chemother Pharmacol 62:11-8. 2008
    ..To evaluate the response rate of the combination of capecitabine (C) and vinorelbine (V) followed by Docetaxel (D) in the 1st line treatment of advanced and metastatic breast cancer patients...
  4. ncbi Experience with palliative care in patients with advanced cancer at a tertiary care hospital in a developing country
    Marwan Ghosn
    Hotel Dieu de France University Hospital, Achrafieh, Beirut, Lebanon
    Support Care Cancer 19:573-5. 2011
    ..Revisiting the continuum of cancer care is called for to better identify the optimal timing of intervention and avoid end of life distress...
  5. ncbi Triple-negative breast cancer in Lebanon: a case series
    Marwan Ghosn
    Saint Joseph University School of Medicine, Beirut, Lebanon
    Oncologist 16:1552-6. 2011
    ..To determine the incidence, characteristics, and survival outcomes of triple-negative breast cancer patients in a medical oncology practice in Lebanon...
  6. ncbi Current strategies in the treatment of metastatic hormone-refractory prostate cancer
    Marwan Ghosn
    Hematology-Oncology Department, , Beirut, Lebanon
    Tunis Med 83:74. 2005
  7. ncbi Outcome of cancer patients admitted to the intensive care unit (ICU)
    Marwan Ghosn
    Department of Hematology-Oncology, , Beirut, Lebanon
    J Med Liban 50:132-6. 2002
    ..The duration of stay in the ICU was the only factor affecting mortality. Age, disease type and MV did not influence the mortality rate in this population...
  8. ncbi [A five-year experience in conformational radiotherapy in the treatment of prostate cancer. Evaluation of acute toxicity in 131 patients]
    Elie Nasr
    Service de Radiotherapie, Hotel Dieu de France, Université Saint Joseph, Beyrouth, Liban
    Prog Urol 15:36-9. 2005
    ..To evaluate the urinary and rectal toxicity secondary to 3D conformal radiotherapy for prostate cancer...